Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Fagan

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Gut|July 1, 1986
Serological responses to HBV infectionE A Fagan, R Williams
Seminars in Liver Disease|November 1, 1984
Non-A, non-B hepatitisE A Fagan, R Williams
The British Journal of Clinical Practice|January 1, 1987
Hepatitis B vaccinationE A Fagan, R Williams
Postgraduate Medical Journal|February 1, 1995
Immunotherapy in the management of sepsisE A Fagan, M Singer
Journal of Hepatology|October 1, 1994
Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitisE A Fagan, T J Harrison
Gut|February 1, 1987
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cellsE A Fagan, A L Eddleston
Lancet (London, England)|September 5, 1987
Hepatitis B vaccine: responder status and timing of additional booster dosesE A Fagan, R Williams, A L Eddleston
Gut|December 1, 1983
Sulindac hepatotoxicityE A Fagan, N Walford, H J Hodgson
Journal of Hepatology|March 1, 1991
Cytoprotective effects of calcium channel blockers. Mechanisms and potential applications in hepatocellular injuryC D Deakin, E A Fagan, R Williams
Digestion|January 1, 1983
SeHCAT absorption: a simple test of ileal dysfunctionE A Fagan, V S Chadwick, I M Baird
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Gut|July 1, 1986
Serological responses to HBV infectionE A Fagan, R Williams
Seminars in Liver Disease|November 1, 1984
Non-A, non-B hepatitisE A Fagan, R Williams
The British Journal of Clinical Practice|January 1, 1987
Hepatitis B vaccinationE A Fagan, R Williams
Postgraduate Medical Journal|February 1, 1995
Immunotherapy in the management of sepsisE A Fagan, M Singer
Journal of Hepatology|October 1, 1994
Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitisE A Fagan, T J Harrison
Gut|February 1, 1987
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cellsE A Fagan, A L Eddleston
Lancet (London, England)|September 5, 1987
Hepatitis B vaccine: responder status and timing of additional booster dosesE A Fagan, R Williams, A L Eddleston
Gut|December 1, 1983
Sulindac hepatotoxicityE A Fagan, N Walford, H J Hodgson
Journal of Hepatology|March 1, 1991
Cytoprotective effects of calcium channel blockers. Mechanisms and potential applications in hepatocellular injuryC D Deakin, E A Fagan, R Williams
Digestion|January 1, 1983
SeHCAT absorption: a simple test of ileal dysfunctionE A Fagan, V S Chadwick, I M Baird
Pageof 7